PTH and osteoporosis: Teriparatide is a recombinant peptide of the first 34 amino-N-terminal residues of parathormone (PTH), which is given daily via subcutaneous route for treatment of age-related and glucocorticoid-induced osteoporosis (Drüeke and Massy, 2016).